Hospitals will spend up to 3% more on drugs in 2023, study finds
(By Paige Twenter for Becker’s Hospital Review) Nonfederal hospitals’ costs have hovered around $35 billion to $40 billion since 2018,
Read More(By Paige Twenter for Becker’s Hospital Review) Nonfederal hospitals’ costs have hovered around $35 billion to $40 billion since 2018,
Read More(By Juliette Cubanski for Kaiser Family Foundation Published: Apr 20, 2023) The Inflation Reduction Act of 2022 (the Act), signed
Read More(By Rylee Wilson for Becker’s Hospital Review) Pharmaceutical Research and Manufacturers of America says CMS’ guidance for Medicare drug price
Read More(By Rachel Cohrs for STAT) WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate,
Read More(By Rylee Wilson for Becker’s Hospital Review) Payers have been required to post all of their negotiated rates in publicly
Read More(By Rylee Wilson for Becker’s Hospital Review) Seven of the 10 drugs most likely to be selected for Medicare price negotiation
Read More(Andrew Cass for Becker’s Hospital Review) Reduced Medicare and Medicaid payments are having more physicians considering reducing those patient bases,
Read More(By Rylee Wilson for Becker’s Hospital Review) HHS has removed seven drugs from its initial list of 27 drugs subject
Read More(By Giles Bruce for Becker’s Hospital Review) Medicare is paying too much for telehealth and at-home care, the executive director of
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS will move ahead with Medicare Advantage risk adjustment changes payers and some
Read More